GFP-expressing influenza a virus for evaluation of the efficacy of antiviral agents

Journal of Microbiology

Volumn 50, Issue 2, 2012, Pages 359-362

  Kim, Jin Il ^a   Park, Sehee ^a   Lee, Ilseob ^a   Lee, Sangmoo ^a   Shin, Saem ^a   Won, Yongkwan ^a   Hwang, Min Woong ^a   Bae, Joon Yong ^a   Heo, Jun ^a   Hyun, Hye Eun ^a   Jun, Hyejin ^a   Lim, Soon Sung ^a   Park, Man Seong ^a  

^a Hallym University   (South Korea)

Author keywords

antiviral drug; green fluorescent protein; influenza

Indexed keywords

ANTIVIRUS AGENT; ENZYME INHIBITOR; GREEN FLUORESCENT PROTEIN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DRUG EFFECT; DRUG SCREENING; FEMALE; GENETICS; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; METABOLISM; METHODOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY; VIROLOGY; VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; DRUG EVALUATION, PRECLINICAL; ENZYME INHIBITORS; FEMALE; GREEN FLUORESCENT PROTEINS; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICE; MICE, INBRED BALB C; VIRULENCE;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 84860364534     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-012-2163-9     Document Type: Article

References (15)

1. Cheng, P. K., To, A. P., Leung, T. W., Leung, P. C., Lee, C. W., and Lim, W. W. 2010. Oseltamivir- and amantadine-resistant influenza virus A (H1N1). Emerg. Infect. Dis. 16, 155-156.
2. De Clercq, E. 2006. Antiviral agents active against influenza A viruses. Nat. Rev. Drug. Discov. 5, 1015-1025.
3. Garcia-Sastre, A., Egorov, A., Matassov, D., Brandt, S., Levy, D. E., Durbin, J. E., Palese, P., and Muster, T. 1998. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology252, 324-330.
4. Guan, Y., Vijaykrishna, D., Bahl, J., Zhu, H., Wang, J., and Smith, G. J. 2010. The emergence of pandemic influenza viruses. Protein Cell1, 9-13.
5. Kawaoka, Y. 2006. Influenza virology: current topics. pp. 203-228, Caister Academic Press, Norfolk, England, UK.
6. Kilbourne, E. D. 2006. Influenza pandemics of the 20th century. Emerg. Infect. Dis. 12, 9-14.
7. Kobasa, D., Jones, S. M., Shinya, K., Kash, J. C., Copps, J., Ebihara, H., Hatta, Y., Kim, J. H., Halfmann, P., Hatta, M., andet al. 2007. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature445, 319-323.
8. Kumar, P., Bartoszek, A. E., Moran, T. M., Gorski, J., Bhattacharyya, S., Navidad, J. F., Thakar, M. S., and Malarkannan, S. 2012. High-throughput detection method for influenza virus. J. Vis. Exp. doi: 10. 3791/3623.
9. Manicassamy, B., Manicassamy, S., Belicha-Villanueva, A., Pisanelli, G., Pulendran, B., and Garcia-Sastre, A. 2010. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. USA107, 11531-11536.
10. Neumann, G. and Kawaoka, Y. 2011. The first influenza pandemic of the new millennium. Influenza Other Respi Viruses5, 157-166.
11. Palese, P. 2004. Influenza: old and new threats. Nat. Med. 10, S82-87.
12. Reed, L. J. and Muench, H. M. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27, 493-497.
13. Soto-Abraham, M. V., Soriano-Rosas, J., Diaz-Quinonez, A., Silva-Pereyra, J., Vazquez-Hernandez, P., Torres-Lopez, O., Roldan, A., Cruz-Gordillo, A., Alonso-Viveros, P., and Navarro-Reynoso, F. 2009. Pathological changes associated with the 2009 H1N1 virus. N. Engl. J. Med. 361, 2001-2003.
14. Thorlund, K., Awad, T., Boivin, G., and Thabane, L. 2011. Systematic review of influenza resistance to the neuraminidase inhibitors. BMC Infect. Dis. 11, 134.
15. Yen, H. L., Ilyushina, N. A., Salomon, R., Hoffmann, E., Webster, R. G., and Govorkova, E. A. 2007. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J. Virol. 81, 12418-12426.